首创置业(02868.HK)全资附属向合夥基金初始投资5.9亿人币
首创置业(02868.HK)公布,董事会通过全资附属首金嘉创作为有限合夥人,向天津和谐霓鲤股权投资基金合夥投资最多9.4亿元人民币(下同)。有关基本之初始资本承担为10.41亿元,首金嘉创作为有限合夥人向该基金初始投资5.9亿元,另外上海丰实作为有限合夥人向该基金投资4.5亿元,另外和谐汇投资管理作为普通合夥人向该基金投资100万元。
公司预计,和谐汇投资管理後将引入其他有限合夥人向该基金投资最少2.7亿元,首金嘉创将作为有限合夥人,将向该基金进一步投资最多3.5亿元,料该基金投资规模合计最多16.61亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.